Status:
RECRUITING
Feasibility Study of a New Immunoglobulin E (IgE) Assay Method
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Allergy and Immunology
Eligibility:
All Genders
6-99 years
Brief Summary
The main objective is to study the feasibility of a new specific IgE assay using a bioluminescence technique in a pediatric and adult allergic population. For this, we will collect blood, and urine du...
Detailed Description
Allergy is a raising public health problem. Specific IgE assays are useful tools to investigate the physiopathology of allergies. This method is achieved mainly by the ImmunoCAP enzyme immunoassay tec...
Eligibility Criteria
Inclusion
- Males or females 6 months' old or older
- Sensitization or allergy towards a trophallergen, an aeroallergen, hymenoptera venom or drug proven by:
- positive skin test (s)
- and / or IgE specific (s)\> 0.1 kUA / L
- and / or anamnesis in favor of an allergic reaction of mediated IgE
- Social coverage up to date
Exclusion
- Children younger than 6 months'old
- Children's weight less than 10 kg
- Pregnant or breastfeeding women
- Patients with cystic fibrosis
- Patients with dysimmune or autoimmune pathology
- Anamnesis in favor of a delayed allergy or a contact allergy.
Key Trial Info
Start Date :
April 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 7 2026
Estimated Enrollment :
1376 Patients enrolled
Trial Details
Trial ID
NCT04751760
Start Date
April 20 2021
End Date
January 7 2026
Last Update
March 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Toulouse, France, 31000
2
Larrey hospital
Toulouse, France, 31059